The U.S. has relied on cheap, effective generic drugs for 40 years. Now that promise is under threat.
Articles
Sending Unarmed Responders Instead of Police: What We’ve Learned
There are more than 100 response teams nationwide, but experts say more research on their impact is needed.
The Fifth Branch Special Credits
This is a special thank you to all of the people who participated in our reporting for The Fifth Branch, our new podcast series.
Why Supporting Caregivers Could Make a Difference in Dementia Care
Patients and their caregivers are often left to navigate the confusing world of dementia by themselves, but Medicare is launching a new program to change that.
A New Kind of Primary Care Comes to America
A group of nurses in East Baltimore is piloting a bold plan to bring basic primary care to everybody no matter their age, income or insurance. Can this idea from abroad take root in the United States?
A Report Card for Telehealth: What’s Worked and What Hasn’t
As Congress figures out the future of telehealth, we get a reality check from a top researcher about what this care has and has not delivered.
Is Private Equity Ruining Health Care? It’s Complicated
While stories of private equity firms running amok in health care are easy to find, new research paints a more nuanced picture.
The Hunt for Lasting Fixes to America’s Medical Debt Crisis
A major new study throws cold water on a popular approach to relieving medical debt, but the research also reveals a promising path forward.
How Do You Help Patients Who Show Up in the ER 100 Times a Year?
Health care leaders share what they’ve learned from two decades of trying to keep this group of costly, complicated patients out of the hospital.
An Insurance Company Bought This Doctor’s Practice. She’s Worried About Her Patients
One doctor debates whether to work for the nation’s largest insurance company after it purchased the independent practice she worked for in Oregon.
